Approval · Notice of Compliance 3105 · 1998
ZYPREXA: Notice of Compliance 3105
Issued November 9, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3105
- Date
- November 9, 1998
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths
- Therapeutic class
- Antipsychotic agent
Products in this notice
Medicinal ingredients
- OLANZAPINE 15 MG per TAB
- OLANZAPINE 20 MG per TAB